Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (Q2)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 22.61%434.96B | -19.44%372.5B | -3.57%1.55T | 354.74B | 462.37B | 102.36%1.61T | 52.47%794.26B | -15.90%520.94B | 619.4B | 18.38%197.8B |
Net profit before non-cash adjustment | 2.42%340.29B | -1.14%372.92B | -10.93%1.26T | --332.27B | --377.24B | 120.09%1.42T | 854.77%643.46B | -86.79%67.39B | --510.29B | 7.17%140.14B |
Total adjustment of non-cash items | 331.66%81.18B | 33.86%47.36B | -5.02%251.06B | --18.81B | --35.38B | 12.08%264.32B | -41.27%235.83B | 123.58%401.58B | --179.61B | 17.35%47.69B |
-Depreciation and amortization | 17.98%96.59B | 19.40%92B | -13.37%261.2B | --81.87B | --77.05B | 43.56%301.52B | 16.14%210.04B | 28.59%180.86B | --140.65B | 111.74%45.32B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 245.16%89.05B | ---- | ---- | 82.07%25.8B | -92.54%14.17B | 23,761.81%189.94B | --796M | ---- |
-Assets reserve and write-off | ---- | ---- | 186.14%5.8B | ---- | ---- | -727.76%-6.74B | 57.32%-814M | -141.70%-1.91B | --4.57B | 4,493.94%4.55B |
-Share of associates | -162.63%-27.29B | -2.18%-50.49B | 75.30%-40.92B | --43.57B | ---49.42B | -326.65%-165.68B | -398.75%-38.83B | 155.76%13B | ---23.31B | -82.50%-10.48B |
-Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---1.48B | --0 |
-Net exchange gains and losses | -89.22%129M | -146.63%-1.74B | -15.80%-6.37B | --1.2B | --3.73B | -140.39%-5.5B | 183.18%13.62B | 743.78%4.81B | ---747M | -29.36%-2.8B |
-Other non-cash items | 110.89%11.75B | 89.02%7.59B | -150.21%-57.7B | ---107.83B | --4.02B | 205.27%114.92B | 153.06%37.65B | -74.84%14.88B | --59.14B | -58.94%11.11B |
Changes in working capital | 267.23%13.49B | -196.05%-47.79B | 151.13%37.47B | --3.67B | --49.75B | 13.82%-73.27B | -263.61%-85.03B | 173.71%51.97B | ---70.51B | 331.77%9.98B |
-Change in receivables | -16.95%14.19B | -216.96%-57.41B | 200.67%67.84B | --17.09B | --49.09B | 26.45%-67.39B | -227.73%-91.62B | 307.08%71.73B | ---34.64B | 134.15%1.99B |
-Change in inventory | 188.39%921M | -590.16%-7.97B | 105.66%913M | ---1.04B | --1.63B | -11.05%-16.14B | -323.36%-14.53B | 956.18%6.51B | ---760M | -217.31%-4.88B |
-Change in payables | 110.79%1.37B | 1,023.97%17.43B | -196.97%-25.71B | ---12.73B | ---1.89B | 21.10%26.51B | 177.99%21.89B | -10.78%-28.07B | ---25.34B | 1,448.07%11.21B |
-Provision for loans, leases and other losses | -936.87%-3B | -81.84%168M | 94.21%-835M | --358M | --925M | -105.72%-14.41B | -458.73%-7.01B | -56.57%1.95B | --4.5B | -28.28%1.66B |
-Changes in other current assets | ---- | ---- | -156.52%-4.74B | ---- | ---- | -129.61%-1.85B | 4,314.19%6.24B | 98.96%-148M | ---14.27B | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 65.81%6.63B | 442.58%12.21B | 4B | 2.25B | ||||||
Interest paid (cash flow from operating activities) | -12.64%-14.98B | 6.45%-15.82B | -156.51%-51.34B | -13.3B | -16.91B | -74.57%-20.02B | 41.18%-11.47B | -10.76%-19.49B | -17.6B | -192.75%-9.61B |
Interest received (cash flow from operating activities) | 21.88%56.94B | 13.86%3.83B | 66.65%116.79B | 46.72B | 3.36B | 354.95%70.08B | 60.99%15.4B | -7.65%9.57B | 10.36B | -66.03%1.74B |
Tax refund paid | -38.58%-254.79B | -7.50%-232.48B | 8.50%-829.05B | -183.86B | -216.27B | -156.86%-906.02B | -61.73%-352.74B | 35.36%-218.1B | -337.43B | 3.37%-96.45B |
Other operating cash inflow (outflow) | 1M | 0 | -1M | 0 | 0 | 0 | 0.00%-1M | -1M | 0 | -2M |
Operating cash flow | 9.82%228.77B | -40.28%140.23B | 4.66%786.32B | --208.31B | --234.81B | 68.65%751.28B | 52.08%445.46B | 6.62%292.92B | --274.73B | 35.26%93.48B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -49.55%-77.98B | -38.71%-76.32B | -5.34%-202.46B | ---52.14B | ---55.02B | -29.85%-192.19B | -9.56%-148.01B | 7.06%-135.1B | ---145.36B | 39.82%-31.8B |
Net intangibles purchase and sale | ---- | ---- | -103.30%-3.82B | ---- | ---- | 32.04%-1.88B | 18.28%-2.76B | -176.82%-3.38B | ---1.22B | -24.73%-454M |
Net business purchase and sale | 11.33%-6.36B | -36.02%-53.56B | --0 | ---7.17B | ---39.38B | ---31.41B | --0 | ---- | ---- | ---- |
Net investment product transactions | 1.00%-165.82B | 120.57%25.01B | -53.61%-253.93B | ---167.5B | ---121.57B | -857.07%-165.31B | 61.64%-17.27B | -30.22%-45.03B | ---34.58B | -127.57%-11.34B |
Advance cash and loans provided to other parties | 85.21%-1.04B | -4,142.60%-33.26B | 98.87%-3.78B | ---7.01B | ---784M | -861.62%-335.3B | 58.90%-34.87B | 25.43%-84.83B | ---113.75B | 103.10%862M |
Repayment of advance payments to other parties and cash income from loans | 41.82%59.64B | -94.36%2.49B | -4.00%152.15B | --42.05B | --44.15B | 128.47%158.5B | 72.96%69.37B | 656.90%40.11B | --5.3B | -233.33%-20M |
Net changes in other investments | 86.62%-3.16B | -29.81%12.2B | -129.79%-12.52B | ---23.6B | --17.38B | 1,392.96%42.01B | 101.49%2.81B | -21,894.93%-188.96B | --867M | -105.05%-336M |
Investing cash flow | 9.59%-194.71B | 20.47%-123.45B | 38.29%-324.35B | ---215.37B | ---155.22B | -302.04%-525.57B | 68.66%-130.73B | -44.49%-417.19B | ---288.74B | -29.90%-43.09B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 80.64%-2.99B | 182.65%48.99B | -377.17%-281.19B | ---15.46B | ---59.28B | 62.16%-58.93B | -190.66%-155.72B | 1,689.71%171.77B | ---10.81B | -90.86%6.23B |
Net common stock issuance | ---- | ---- | 17.49%-100B | ---- | ---- | -14.90%-121.19B | ---105.48B | ---- | ---- | ---- |
Increase or decrease of lease financing | -20.98%-5.97B | -23.46%-5.76B | ---- | ---4.93B | ---4.67B | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -15.61%-10.21B | -10.26%-36.35B | -12.12%-90.15B | ---8.84B | ---32.97B | -72.09%-80.4B | -6.67%-46.72B | -11.07%-43.8B | ---39.43B | -66.37%-4.15B |
Cash dividends for minorities | --0 | -120.88%-10.02B | 25.55%-8.29B | ---132M | ---4.54B | -213.98%-11.14B | 13.42%-3.55B | 39.06%-4.1B | ---6.73B | -75.03%-4.05B |
Net other fund-raising expenses | -78.93%79M | 469.16%4.14B | -102.37%-705M | --375M | ---1.12B | 893.04%29.73B | -230.49%-3.75B | -65.58%2.87B | --8.35B | 1,398.55%1.79B |
Financing cash flow | -52.11%-44.1B | 100.98%1B | -98.55%-480.34B | ---28.99B | ---102.57B | 23.25%-241.93B | -348.70%-315.22B | 360.72%126.75B | ---48.62B | -100.28%-174M |
Net cash flow | ||||||||||
Beginning cash position | 24.61%227.31B | -3.40%201.15B | 10.69%211.66B | --182.42B | --208.24B | 10.91%191.21B | -0.79%172.41B | -27.49%173.77B | --239.65B | 8.81%170.39B |
Current changes in cash | 72.15%-10.04B | 177.37%17.79B | -13.22%-18.36B | ---36.05B | ---22.99B | -3,243.92%-16.22B | -119.61%-485M | 103.95%2.47B | ---62.63B | -49.35%50.21B |
Effect of exchange rate changes | 78.48%15.88B | 395.90%8.38B | -79.31%7.59B | --8.9B | ---2.83B | 90.03%36.66B | 602.16%19.29B | -18.11%-3.84B | ---3.25B | -127.47%-1.46B |
Cash adjustments other than cash changes | ---- | ---- | ---- | --1M | ---2M | ---1M | ---- | ---- | ---- | ---- |
End cash Position | 50.17%233.16B | 24.61%227.31B | -5.09%200.88B | --155.27B | --182.42B | 10.69%211.66B | 10.91%191.21B | -0.79%172.41B | --173.77B | -16.04%219.15B |
Free cash flow | -3.44%150.79B | -64.45%63.91B | 4.53%579.73B | --156.17B | --179.79B | 88.33%554.62B | 91.19%294.49B | 20.43%154.03B | --127.9B | 285.19%61.22B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |